Clinical characterization and identification of rare genetic variants in atypical hemolytic uremic syndrome: A Swedish retrospective observational study-Reference-Cited by-同舟云学术

Clinical characterization and identification of rare genetic variants in atypical hemolytic uremic syndrome: A Swedish retrospective observational study

Published:2021-03-31 Issue:6 Volume:25 Page:988-1000
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Åkesson Alexander¹^ORCID,Martin Myriam²,Blom Anna M.²,Rossing Maria³,Gabrielaite Migle³,Zetterberg Eva¹,Klintman Jenny¹

Affiliation:

1. The Clinical Coagulation Research Unit, Department of Translational Medicine Lund University, Skane University Hospital Malmo Sweden

2. The Medical Protein Chemistry Research Group, Department of Translational Medicine Lund University Malmo Sweden

3. Centre for Genomic Medicine, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Funder

Sveriges Regering

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13634

Reference32 articles.

1. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

2. Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults

3. Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype

4. aHUS: a disorder with many risk factors

5. Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic investigation of Nordic patients with complement-mediated kidney diseases;Frontiers in Immunology;2023-09-07

2. Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic;Immunobiology;2023-09

3. Analysis of 3 Cases of Postpartum Hemolytic Uremia and Review of Literature;Advances in Clinical Medicine;2023

4. Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case report;European Heart Journal - Case Reports;2021-09-28